Abstract
Several experimental human DNA vaccines are currently undergoing Phase I, II, and III clinical trials in order to investigate their efficacy and safety. Human clinical trials must follow guidelines and procedures that have been approved by the regulatory authorities and ethics committees. Ethical clinical research is much more than applying an informed consent to participants. In this chapter we will review the ethical standards and provide a framework to evaluate and design ethical clinical research. Despite being universal standards supported by universal guidelines, they must be adapted to the conditions in each country where the clinical research is being conducted.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Zhang A (2015) DNA vaccines: scientific and ethical barriers to the vaccines of the future. Harvard College Global Health Review, Cambridge
Myhr AI (2017) DNA vaccines: regulatory considerations and safety aspects. Curr Issues Mol Biol 22:79–88
Spier RE (2004) Ethical aspects of the methods used to evaluate the safety of vaccines. Vaccine 22:2085–2090
Plotkin S (2011) Clinical applications of DNA vaccines: current progress. Clin Infect Dis 53:296–302
Parents Requesting Open Vaccine Education (PROVE) (2000) Conflicts of interest in vaccine policy making. Majority Staff Report, Committee on Government Reform, U.S. House of Representatives
Doussau A, Grady C (2016) Deciphering assumptions about step wedge designs: the case of Ebola vaccine research. J Med Ethics 42:797–804
Bhanot N, Mehta K (2012) Wrong at every step: the licensing of HPV vaccines. Mainstream Weekly 32
Johari V (2017) Identifying ethical issues in the development of vaccines and in vaccination. Indian J Med Ethics 2(2):88–93
Molyneux M (2017) New ethical considerations in vaccine trials. Hum Vaccin Immunother 13:2160–2163
van Luijn HEM, Musschenga AW, Keus RB et al (2002) Assessment of the risk/benefit ratio of phase II cancer clinical trials by Institutional Review Board (IRB) members. Ann Oncol 8:1307–1313
Emanuel EJ, Wendler D, Grady C (2000) What makes clinical research ethical. JAMA 283:2701–2711
ICH (2015) Integrated addendum to ICH E6(R1): Guideline for Good Clinical Practice E6(R2)
EMA (2013) Reflection paper on risk-based quality management in clinical trials
Piantadosi S (2013) Clinical trials: a methodologic perspective. John Wiley & Sons, Hoboken, NJ
Nijhawan LP, Janodia MD, Muddukrishna BS et al (2013) Informed consent: issues and challenges. J Adv Pharm Technol Res 4:134–140
Kadam RA (2017) Informed consent process: a step further towards making it meaningful! Perspect Clin Res 8:107–112
Ghooi RB (2015) Conflict of interest in clinical research. Perspect Clin Res 6:10–14
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Ramalhinho, A.C., Castelo-Branco, M. (2021). Ethics of DNA Vaccine Transfer for Clinical Research. In: Sousa, Â. (eds) DNA Vaccines. Methods in Molecular Biology, vol 2197. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-0872-2_17
Download citation
DOI: https://doi.org/10.1007/978-1-0716-0872-2_17
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-0871-5
Online ISBN: 978-1-0716-0872-2
eBook Packages: Springer Protocols